Double Relief: Study evaluates Synergistic Effects of Hydromorphone and Ropivacaine in Thoracoscopic Surgery Dr Monish Raut19 Aug 2025 8:15 PM ISTRecently published clinical trial aimed to evaluate the efficacy of hydromorphone as an adjunct to ropivacaine in serratus anterior plane block (SAPB)...
Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer Ruchika Sharma19 Aug 2025 2:15 PM ISTPrinceton: SystImmune Inc., a clinical-stage biotechnology company, and Bristol Myers Squibb have announced that the U.S. Food and Drug...
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer Ruchika Sharma19 Aug 2025 12:30 PM ISTRahway: Merck and Daiichi Sankyo have announced that Ifinatamab deruxtecan (I-DXd) has been granted Breakthrough Therapy Designation (BTD) by the...
Medical Bulletin 13/August/2025 Dr. Bhumika Maikhuri13 Aug 2025 3:00 PM ISTHere are the top medical news for the day:5 Lifestyle Habits May Cut Heart Disease Risk by 86% in Women with Gestational DiabetesA study published in...
Thermo Fisher gets USFDA nod for NGS-based Companion Diagnostic for new Non Small Cell Lung Cancer treatment Ruchika Sharma13 Aug 2025 5:40 PM ISTCarlsbad: Thermo Fisher Scientific has received approval from the U.S. Food and Drug Administration (FDA) for its Oncomine Dx Target Test as a...
New Web-Based Tool Aims to Cut Lung Cancer Deaths with Tailored Strategies, Reveals Research Dr. Bhumika Maikhuri13 Aug 2025 8:15 AM ISTIn a major step toward tackling cancer-related deaths, experts have developed a customizable, web-based planning tool designed to help implement...
FDA Grants Accelerated Approval to Zongertinib for HER2-Mutated NSCLC Dr. Kamal Kant Kohli11 Aug 2025 8:15 PM ISTThe FDA has granted accelerated approval to zongertinib (Hernexeos) for treating non-squamous non-small cell lung cancer patients with HER2 tyrosine...
Boehringer Hernexeos gets USFDA accelerated approval for previously treated patients with HER2-mutant advanced NSCLC Ruchika Sharma11 Aug 2025 3:15 PM ISTRidgefield: Boehringer Ingelheim's HERNEXEOS (zongertinib tablets) has received approval from the U.S. Food and Drug Administration (FDA). The...
Gujarat Cancer and Research Institute Treats over 4,300 patients in 4 years Yakshi Chugh4 Aug 2025 5:54 PM ISTGujarat Cancer and Research Institute Treats over 4,300 patients in 4 years, urges early screening The Gujarat Cancer and Research Institute (GCRI)...
Health Bulletin 04/August/ 2025 Yakshi Chugh4 Aug 2025 5:28 PM ISTHere is the top health news for today: Vasopressor Complication Costs Patient Fingers; Hospital, Doctors slapped Rs 6 lakh compensation for...
Gujarat Cancer and Research Institute Treats over 4,300 patients in 4 years, urges early screening Kajal Rajput3 Aug 2025 12:45 PM ISTGandhinagar: The Gujarat Cancer and Research Institute (GCRI) in Ahmedabad has treated 4,397 cancer patients between 2020 and 2024, reinforcing...
Sausages, Sodas, and Cancer: Ultra-Processed Foods May Be Linked to Higher Lung Cancer Risk Dr. Bhumika Maikhuri1 Aug 2025 8:30 AM ISTA high intake of ultra-processed foods (UPFs) is associated with an increased risk of lung cancer, according to new research published in thejournal...
